The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C
about
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during DiseasesCompartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfectionInterferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.Natural killer and natural killer T cells in liver fibrosisNK cell isolation from liver biopsies: phenotypic and functional analysis of low cell numbers by flow cytometry.Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.The natural killer cell response to HCV infection.Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.NK cell trafficking in health and autoimmunity:a comprehensive review.Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunologyImmunology in the liver--from homeostasis to disease.Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells.IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells.Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.Frequency and phenotype of human circulating and intrahepatic natural killer cell subsets is differentially regulated according to stage of chronic liver disease.
P2860
Q28079140-F1DA2553-93CA-45E9-98B2-D7D05F1664F7Q33831703-E0FF434E-29B5-41EB-8CE2-524A071D907FQ36093940-EB6A3CA6-4413-42C1-9D40-35875CE63972Q36553227-68D3FD4B-4E91-4EFF-8729-E2C00ED20790Q36672216-731F5565-F013-459D-8113-83B8B78ADF90Q36810593-6452E417-973B-4F6D-9657-E9A3487FE92FQ37279158-AC74E31A-A9CE-4549-99B6-E26C55195810Q37358617-83573473-21B6-47E5-BA65-2D5B6FD4F276Q38173696-CBD5994F-F80B-4C65-B0A6-3BBCED1DE143Q38311151-B8F04ECF-B0B0-4875-98DA-9C7D36BF04D7Q38693925-1C991B9A-9309-4F4E-9E1B-1781164D5571Q40089171-4262DB7B-767F-4013-BCBC-D76DF74ABCF0Q41756934-F5626B02-CBCA-4BE0-91AA-F567EA6F8935Q41760166-B49C86BC-B250-4D3B-A5DB-016F29AC133AQ43704795-F50FC14E-E34F-4D17-B49C-4DA93BC8778D
P2860
The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The CXCR3
@nl
The CXCR3(+)CD56Bright phenoty ...... ulated activity in hepatitis C
@ast
The CXCR3(+)CD56Bright phenoty ...... ulated activity in hepatitis C
@en
type
label
The CXCR3
@nl
The CXCR3(+)CD56Bright phenoty ...... ulated activity in hepatitis C
@ast
The CXCR3(+)CD56Bright phenoty ...... ulated activity in hepatitis C
@en
prefLabel
The CXCR3
@nl
The CXCR3(+)CD56Bright phenoty ...... ulated activity in hepatitis C
@ast
The CXCR3(+)CD56Bright phenoty ...... ulated activity in hepatitis C
@en
P2093
P2860
P50
P1433
P1476
The CXCR3(+)CD56Bright phenoty ...... ulated activity in hepatitis C
@en
P2093
Andreas Glässner
Bernhard Sibbing
Jacob Nattermann
Marianne Eisenhardt
Pavlos Kokordelis
Tilman Sauerbruch
Ulrich Spengler
P2860
P304
P356
10.1371/JOURNAL.PONE.0038846
P407
P577
2012-07-05T00:00:00Z